Details for the registration for the 2nd phase of covid vaccination

Details for the registration for the 2nd phase of covid vaccination

Senior citizens and people over 45 years of age with co-morbidities can follow the given process for registration of vaccination to begin from 1st March.
 
Details for the registration for the 2nd phase of covid vaccination

-Details for the 2nd phase of registration are given here.

-For those who are not able to self-register can approach registration windows in hospitals and Common Service Centres. The registration is free of cost.

The 2nd phase of covid vaccination will begin from 1st March. Senior citizens and people above 45 years of age with co-morbidities can register for the vaccination on the Co-Win App, the new version of which will be launched soon. The registration is not limited to online channels. The next phase will cover people over 50 years of age with no co-morbidities for vaccination.

There are people who may not be well versed with the online registration system or are not able to self-register for the vaccination. These people can approach the registration windows opened at various hospitals and the Common Service Centres. The registration is free of cost.

For the registration, one must download the Co-Win app. The new version of this app will be launched soon. The government also has the data of senior citizens based on the electoral rolls. Those who are well versed with using apps can register themselves on the Co-win app. They can log-in and those who have already been vaccinated can download their certificates by giving the reference ID.

For those above 60 years of age will need to provide a photo ID. Once the data on the age matches, the app will upload any firther information. Those with co-morbidities will be required to furnish a medical certificate, too. The government may issue a form with co-morbidity details mentioned which a prospective beneficiary will have to fill and get signed by a doctor after an examination. These documents will have to be produced during vaccination. Both booked and open slots will be there for this phase of vaccination.

The beneficiaries will be able to choose their vaccine location and time; there will be no choice between Covishield, Oxford-Astrazeneca vaccine, developed in India by Pune's Serum Institute, and Bharat Biotech's Covaxin. 

For the latest updates from UdaipurTimes, subscribe to our Channels on GOOGLE NEWS | WHATSAPP | SIGNAL | TELEGRAM. Also follow UdaipurTimes on FacebookTwitter and Instagram.

 

To join us on Facebook Click Here and Subscribe to UdaipurTimes Broadcast channels on   GoogleNews |  Telegram |  Signal